Education
About Us
Working with TipRanks
Follow Us
Biolidics Ltd. (SG:8YY)
:8YY
Total Valuation
Biolidics Ltd. has a market cap or net worth of S$39.87M. The enterprise value is S$38.80M.
Market CapS$39.87M
Enterprise ValueS$38.80M
Share Statistics
Biolidics Ltd. has 1,733,441,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,733,441,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Biolidics Ltd.’s return on equity (ROE) is -1.98 and return on invested capital (ROIC) is -44.37%.
Return on Equity (ROE)-1.98
Return on Assets (ROA)-0.74
Return on Invested Capital (ROIC)-44.37%
Return on Capital Employed (ROCE)-0.62
Revenue Per Employee112.00K
Profits Per Employee-489.86K
Employee Count7
Asset Turnover0.17
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Biolidics Ltd. is ―. Biolidics Ltd.’s PEG ratio is 0.50.
PE Ratio―
PS Ratio36.30
PB Ratio16.43
Price to Fair Value16.43
Price to FCF-12.27
Price to Operating Cash Flow-13.41
PEG Ratio0.50
Income Statement
In the last 12 months, Biolidics Ltd. had revenue of 784.00K and earned -3.43M in profits. Earnings per share was 0.00.
Revenue784.00K
Gross Profit187.00K
Operating Income-1.70M
Pretax Income-3.19M
Net Income-3.43M
EBITDA-3.03M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -2.68M and capital expenditures -6.00K, giving a free cash flow of -2.69M billion.
Operating Cash Flow-2.68M
Free Cash Flow-2.69M
Free Cash Flow per Share>-0.01
Dividends & Yields
Biolidics Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.11
52-Week Price Change100.00%
50-Day Moving Average0.02
200-Day Moving Average0.02
Relative Strength Index (RSI)48.15
Average Volume (3m)1.76M
Important Dates
Biolidics Ltd. upcoming earnings date is Oct 29, 2025, TBA (Confirmed).
Last Earnings DateAug 12, 2025
Next Earnings DateOct 29, 2025
Ex-Dividend Date―
Financial Position
Biolidics Ltd. as a current ratio of 0.35, with Debt / Equity ratio of 226.17%
Current Ratio0.35
Quick Ratio0.35
Debt to Market Cap0.06
Net Debt to EBITDA-0.48
Interest Coverage Ratio-43.64
Taxes
In the past 12 months, Biolidics Ltd. has paid 5.00K in taxes.
Income Tax5.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Biolidics Ltd. EV to EBITDA ratio is -9.88, with an EV/FCF ratio of -12.90.
EV to Sales38.15
EV to EBITDA-9.88
EV to Free Cash Flow-12.90
EV to Operating Cash Flow-12.93
Balance Sheet
Biolidics Ltd. has S$300.00K in cash and marketable securities with S$2.52M in debt, giving a net cash position of -S$2.21M billion.
Cash & Marketable SecuritiesS$300.00K
Total DebtS$2.52M
Net Cash-S$2.21M
Net Cash Per Share>-S$0.01
Tangible Book Value Per Share>-S$0.01
Margins
Gross margin is 26.30%, with operating margin of -217.09%, and net profit margin of -438.01%.
Gross Margin26.30%
Operating Margin-217.09%
Pretax Margin-406.51%
Net Profit Margin-438.01%
EBITDA Margin-386.22%
EBIT Margin-401.53%
Analyst Forecast
The average price target for Biolidics Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―